Approximately 365 million people in Asia were classified as elderly in 2017. This number is
rising and expected to reach approximately 520 million by 2030. The risk of hypertension …

Background: Diabetes mellitus (DM) is widely spread in South Asian (ASEAN) and Indian
sub-continent. The increasing healthcare costs of DM can be prevented in the developing …

The claim between hypertension and dementia needs more evidence due to limited data.
We aim to examine the risk of dementia in patients with hypertension, and determine …

Glucagon‐like peptide‐1 receptor (GLP‐1R) agonists are a class of newly introduced
antidiabetic medications that potentially lower blood glucose by several molecular …

The drug development pipeline for a new compound can last 10-20 years and cost over $10
billion. Drug repurposing offers a more time-and cost-effective alternative. Computational …

Dementia impairs memory, critical thinking, and decision-making. Alzheimer's disease is
caused by extracellular amyloid fibrils containing the peptide Amyloid beta (Aβ) …

Dementia is a progressive neurological and degenerative syndrome that affects an
individuals' memory, thinking, and social abilities severely enough to interfere with their daily …

Background: Becoming shorter by each cell division, telomere length (TL) is regarded as a
marker of cellular aging. Relative TL (T/S) depends on the quantitation of telomere hexamer …

The elderly population with cognitive decline is increasing at an alarming rate in developing
countries such as India. There is a paucity of basic clinical research in the field of cognitive …

Background: Evidence suggests that modifiable risk factors which can be targeted by
prevention are vascular diseases, such as diabetes, midlife hypertension (HTN), midlife …